Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.27B |
| 2 |
QXO
QXO Inc
QXO
|
+$1.14B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 4 |
Thermo Fisher Scientific
TMO
|
+$505M |
| 5 |
Walt Disney
DIS
|
+$502M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$938M |
| 3 |
Microsoft
MSFT
|
+$734M |
| 4 |
McDonald's
MCD
|
+$609M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$544M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.37% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2.43% |
| 4 | Financials | 2.27% |
| 5 | Industrials | 1.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
PUT
ProShares UltraPro Short QQQ
SQQQ
$1.68B
| $16.9M | ﹤0.01% |
81,680
+26,464
| +48% | +$6.75M |
|
|
ETNB
2127
DELISTED
89bio
ETNB
| $16.9M | ﹤0.01% |
2,109,082
+539,540
| +34% | +$4.82M |
|
2128
CALL
CDW
CDW
$17.4B
| $16.9M | ﹤0.01% |
75,400
-41,600
| -36% | -$9.65M |
|
2129
PUT
Navios Maritime Partners
NMM
$2.33B
| $16.9M | ﹤0.01% |
330,400
+151,800
| +85% | +$7.04M |
|
2130
CALL
Keysight
KEYS
$61.1B
| $16.8M | ﹤0.01% |
123,200
-15,200
| -11% | -$2.22M |
|
2131
PUT
Nextpower Inc
NXT
$15.4B
| $16.8M | ﹤0.01% |
358,431
+80,042
| +29% | +$3.98M |
|
2132
CALL
Textron
TXT
$15.3B
| $16.8M | ﹤0.01% |
195,700
-59,400
| -23% | -$5.29M |
|
|
MRX
2133
Marex Group Limited Ordinary Shares
MRX
$5.11B
| $16.8M | ﹤0.01% |
+839,888
| New | +$16.5M |
|
2134
CALL
Lumentum
LITE
$82.1B
| $16.8M | ﹤0.01% |
329,200
-5,500
| -2% | -$249K |
|
2135
iShares Silver Trust
SLV
$31.5B
| $16.7M | ﹤0.01% |
630,313
-1,420,494
| -69% | -$37.4M |
|
2136
CALL
Elastic
ESTC
$9.01B
| $16.7M | ﹤0.01% |
146,900
-121,100
| -45% | -$12.7M |
|
2137
PUT
BJs Wholesale Club
BJ
$11.9B
| $16.7M | ﹤0.01% |
190,400
+16,800
| +10% | +$1.36M |
|
2138
CALL
TFI International
TFII
$12.1B
| $16.7M | ﹤0.01% |
115,000
+36,600
| +47% | +$5.17M |
|
2139
CALL
British American Tobacco
BTI
$123B
| $16.7M | ﹤0.01% |
539,200
+105,100
| +24% | +$3.19M |
|
2140
Haemonetics
HAE
$4.13B
| $16.7M | ﹤0.01% |
201,522
+183,991
| +1,050% | +$16.2M |
|
2141
CALL
BioNTech
BNTX
$23.4B
| $16.7M | ﹤0.01% |
207,300
+81,300
| +65% | +$7.43M |
|
2142
CALL
Solventum
SOLV
$15.1B
| $16.6M | ﹤0.01% |
+314,800
| New | +$19.1M |
|
2143
Spyre Therapeutics
SYRE
$9.14B
| $16.6M | ﹤0.01% |
707,586
-4
| -0% | -$135 |
|
2144
CALL
Leidos
LDOS
$18B
| $16.6M | ﹤0.01% |
113,800
+57,100
| +101% | +$7.98M |
|
|
DFS
2145
PUT
DELISTED
Discover Financial Services
DFS
| $16.6M | ﹤0.01% |
126,900
-74,300
| -37% | -$9.26M |
|
2146
Thor Industries
THO
$4.11B
| $16.6M | ﹤0.01% |
177,518
+55,856
| +46% | +$5.58M |
|
2147
PUT
PACCAR
PCAR
$68.8B
| $16.6M | ﹤0.01% |
160,900
+42,000
| +35% | +$4.63M |
|
|
IAS
2148
DELISTED
Integral Ad Science
IAS
| $16.6M | ﹤0.01% |
1,703,293
+668,208
| +65% | +$6.4M |
|
2149
CONMED
CNMD
$1.51B
| $16.5M | ﹤0.01% |
238,525
+82,442
| +53% | +$6.01M |
|
2150
CALL
MSCI
MSCI
$41.4B
| $16.5M | ﹤0.01% |
34,300
-700
| -2% | -$347K |
|
Similar funds
Ken Griffin's Q2 2024 Portfolio in Review
As of Q2 2024, Ken Griffin held 15,899 positions worth $494B, down 4.7% from $518B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Ken Griffin withdrew a net $42.4B in Q2 2024, closing 1,760 positions and reducing 6,731 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $1.46B position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in Carrier Global worth $140M.
- Ken Griffin's largest Q2 2024 buy was Carrier Global: 2,220,323 shares worth $140M.
- Ken Griffin added most to Invesco QQQ Trust in Q2 2024, an estimated $1.27B increase.
- Ken Griffin's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $938M.
- Ken Griffin fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $1.46B.
- Ken Griffin's ten largest holdings make up 29% of its $494B portfolio in Q2 2024.
- Ken Griffin opened 1,434 new positions and closed 1,760 in Q2 2024.
- Ken Griffin's portfolio value fell 4.7% quarter-over-quarter to $494B.
Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.